首页> 美国卫生研究院文献>Annals of Thoracic and Cardiovascular Surgery >The Outcomes of Endovascular Aneurysm Repair with the Chimney Technique for Juxtarenal Aortic Aneurysms
【2h】

The Outcomes of Endovascular Aneurysm Repair with the Chimney Technique for Juxtarenal Aortic Aneurysms

机译:烟囱技术治疗近侧主动脉瘤的血管内动脉瘤的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose: We collected our experience in the use of chimney technique with endovascular aneurysm repair (Ch-EVAR) for juxtarenal aortic aneurysms (JAAs), and reviewed the outcomes.Methods: The patients who were treated with Ch-EVAR between January 2012 and December 2015 were retrospectively reviewed. All of the patients underwent endovascular aneurysm repair (EVAR) under general anesthesia. Femoral arterial access was obtained to place the main body of the endograft; brachial or axillary access was obtained to perform the placement of the chimney stent.Results: We treated 12 patients with 15 renal arteries using the Ch-EVAR procedure. Technical success was achieved in 11 of the 12 (91.6%) cases. Within the first 30 days of postoperative period, the target vessel patency rate was 93.3% (14 of 15 renal arteries). After a median follow-up period of 28 months, one patient required Ch-EVAR-related re-intervention due to a type Ia endoleak, and 13 of the 15 renal arteries were patent at the end of the follow-up period.Conclusion: Our findings demonstrate that Ch-EVAR can be completed with a high rate of success. Although early target vessel occlusion or early postoperative mortality might occur, Ch-EVAR could be an alternative treatment for JAA, especially in high risk patients.
机译:目的:我们收集了使用烟囱技术结合血管内动脉瘤修复(Ch-EVAR)治疗近侧主动脉瘤(JAA)的经验,并回顾了结局。方法:2012年1月至12月之间接受Ch-EVAR治疗的患者回顾性审查2015年。所有患者均在全身麻醉下接受血管内动脉瘤修补术(EVAR)。获得股动脉通路以放置内移植物的主体;结果:我们采用Ch-EVAR程序治疗了12例15条肾动脉的患者。 12例中的11例(91.6%)获得了技术成功。在术后的前30天内,目标血管通畅率为93.3%(15条肾动脉中的14条)。在中位随访28个月后,由于Ia型内漏,一名患者需要进行Ch-EVAR相关的再次干预,并且在随访期结束时15条肾动脉中有13条获得了专利。我们的发现表明,Ch-EVAR可以成功完成。尽管可能发生早期靶血管阻塞或术后早期死亡,但Ch-EVAR可能是JAA的替代治疗,尤其是在高危患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号